Steatocystoma multiplex

LAST UPDATED: Dec 02, 2023

Introduction

Steatocystoma multiplex is an uncommon skin condition first described by Jamieson in 1873, and coined by Pringle in 1899. It is a disorder of the pilosebaceous unit characterised by the development of numerous sebum-containing dermal cysts on the upper trunk, and other sites rich in sebaceous glands.

This chapter is set out as follows:


Aetiology

  • Although steatocystoma multiplex can be inherited in an autosomal dominant fashion, most cases are sporadic

History

  • Cysts manifest predominantly during adolescence and early adulthood, although sporadic cases can occasionally arise in older patients
  • Both males and females may be affected

Clinical findings

Distribution

  • The trunk, particularly the presternal skin, and proximal limbs are the most commonly involved sites 
  • Much less commonly lesions may also appear on the face and acral sites

Morphology

  • Multiple skin-coloured to white-yellow, smooth, dermal papules and nodules ranging in size from 3 mm to 3 cm
  • There is no central punctum
  • The cysts are often freely movable 
  • Lesions can occasionally become inflamed, increase in size, and rupture. In such cases secondary bacterial colonisation and sinus tract formation may ensue
  • There may be widespread comedone formation

The differential diagnoses include nodular acne, and in familial cases the condition can be associated with eruptive vellus hair cysts.


Clinical Images

Please refer to notes on image rights at bottom of the page with regards to individual image ownership.


Management

  • There is little in the way of effective medical therapy, although oral isotretinoin may reduce the size of pre‐existing cysts and/or reduce the rate of development of new lesions
  • Treatment with an ablative laser, such as a carbon dioxide laser, appears to be effective

Disclaimer - the author PCDS cannot accept responsibility for any misleading or incorrect statements, and the management of individual patients remains the direct responsibility of the individual doctor. We do however hope that visitors to this site can contact us regarding comments that are considered misleading or incorrect so that we can continue to improve the site.

Image Rights - The PCDS would like to thank Dermatoweb, DermQuest (Galderma), and others who have contributed images. All named individuals and organisations maintain copyright for the relevant images.

Quick Links

The following pharmaceutical companies have had no involvement in the content of this website or in our conference programmes

Almirall
Galderma
Glenmark
Johnson & Johnson
La Roche-Posay
LEO Pharma
Pierre Fabre
Schuco